The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases.
- DOI
- 10.1007/s12325-021-02004-1
- Published
- 2022 Jan
- Container
- Advances in therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-021-02004-1,
title = {The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases.},
author = {Setyawan J and Billmyer E and Mu F and Yarur A and Zichlin ML and Yang H and Downes N and Azimi N and Strand V},
year = {2022},
journal = {Advances in therapy},
doi = {10.1007/s12325-021-02004-1},
url = {https://doi.org/10.1007/s12325-021-02004-1}
}RIS
TY - JOUR TI - The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases. AU - Setyawan J AU - Billmyer E AU - Mu F AU - Yarur A AU - Zichlin ML AU - Yang H AU - Downes N AU - Azimi N AU - Strand V PY - 2022 JO - Advances in therapy DO - 10.1007/s12325-021-02004-1 UR - https://doi.org/10.1007/s12325-021-02004-1 ER -
APA
J, S., E, B., F, M., A, Y., ML, Z., H, Y., N, D., N, A., & V, S. (2022). The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases.. Advances in therapy. https://doi.org/10.1007/s12325-021-02004-1
Source records
- pubmed · retrieved 2026-09-26T02:58:08.499Z